Ehsan Rezaie
Impact in
- Biotechnology top 10%
- Transgenic Plants and Applications
- Microbial Inactivation Methods
-
- Circadian rhythm and melatonin
Papers in
-
- Toxin Mechanisms and Immunotoxins 7
-
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Jafar Amani (6 shared papers)Mohammad Heiat (4 shared papers)Hamideh Mahmoodzadeh Hosseini (3 shared papers)Ali Bidmeshki Pour (2 shared papers)Seyed Moayed Alavian (2 shared papers)Jafar Salimian (4 shared papers)Kazem Hassanpour (2 shared papers)Hossein Aghamollaei (2 shared papers)
- Journals
- Toxins (2 papers)Archives of Medical Research (2 papers)Research in Pharmaceutical Sciences (1 paper)Journal of Biomolecular Structure and Dynamics (1 paper)RSC Advances (1 paper)
- Partner nations
- IranUnited KingdomJapan
In The Last Decade
Ehsan Rezaie
18 papers receiving 324 citations
Peers
Comparison fields: 5 of 68
- Biotechnology 66
- Endocrine and Autonomic Systems 35
- Immunology 109
- Biological Psychiatry 11
- Cancer Research 54
Countries citing papers authored by Ehsan Rezaie
This map shows the geographic impact of Ehsan Rezaie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Rezaie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Rezaie more than expected).
Fields of papers citing papers by Ehsan Rezaie
This network shows the impact of papers produced by Ehsan Rezaie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Rezaie. The network helps show where Ehsan Rezaie may publish in the future.
Co-authors
The 25 scholars most cited alongside Ehsan Rezaie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 60 | |
| 2 | 2019 | 34 | |
| 3 | 2021 | 32 | |
| 4 | 2020 | 27 | |
| 5 | 2021 | 25 | |
| 6 | 2017 | 23 | |
| 7 | 2019 | 21 | |
| 8 | 2021 | 19 | |
| 9 | 2021 | 15 | |
| 10 | 2018 | 14 | |
| 11 | 2018 | 12 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 9 | |
| 14 | 2021 | 9 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 5 | |
| 17 | Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial : Adjuvant treatment of melatonin in COVID-19 patients | 2021 | 2 |
| 18 | 2018 | 1 | |
| 19 | EVALUATION AND COMPARISON OF IMMUNIZATION LEVEL BETWEEN RECOMBINANT PROTEINS OF BINDING SUBUNIT OF ENTROTOXIGENIC ESCHERICHIA COLI AND BOTULINUM TOXIN | 2014 | 1 |
About Ehsan Rezaie
Ehsan Rezaie is a scholar working on Immunology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 19 papers that have together received 327 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), MicroRNA in disease regulation (3 papers), HER2/EGFR in Cancer Research (2 papers), Circadian rhythm and melatonin (2 papers), Phytochemicals and Antioxidant Activities (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Biotechnology (66 citations), Endocrine and Autonomic Systems (35 citations), Immunology (109 citations), Biological Psychiatry (11 citations) and Cancer Research (54 citations). Ehsan Rezaie has collaborated with scholars based in Iran, United Kingdom and Japan. Frequent co-authors include Jafar Amani, Mohammad Heiat, Hamideh Mahmoodzadeh Hosseini, Ali Bidmeshki Pour, Seyed Moayed Alavian, Jafar Salimian, Kazem Hassanpour, Hossein Aghamollaei, Mostafa Akbariqomi and Hadi Esmaeili Gouvarchin Ghaleh. Their work appears in journals such as Toxins, Archives of Medical Research, Research in Pharmaceutical Sciences, Journal of Biomolecular Structure and Dynamics and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.